TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA. November 22, 2006